Empagliflozin-based quadruple oral therapy for type 2 diabetes: a prospective cohort study.
Moosaie F, Abedinzadeh S, Rabizadeh S, Daneshvar K, Noorafrooz M, Mojtahedi FA, Deravi N, Fatemi Abhari SM, Ramezani A, Meysamie A, Hajibabaei M, Reyhan SK, Abbaszadeh M, Nakhjavani M, Esteghamati A.
Moosaie F, et al. Among authors: ramezani a.
Sci Rep. 2025 Jan 9;15(1):1427. doi: 10.1038/s41598-024-84993-x.
Sci Rep. 2025.
PMID: 39789026
Free PMC article.